Clabsi - Central Line Associated Bloodstream Infection Clinical Trials
2 recruiting trials for Clabsi - Central Line Associated Bloodstream Infection. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Clabsi - Central Line Associated Bloodstream Infection clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Hospital de Clinicas de Porto Alegre (1), Fudan University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Subcutaneous tunnelling (procedure, 1 trial), followed by Non-tunnelling, evidence-based intervention Plan for the Prevention of CRBSI in ICU patients.
Track Clabsi - Central Line Associated Bloodstream Infection trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Tunneled Peripherally Inserted Central Catheter (PICC) in Adult Patients and Associated Outcomes
The aim of this multicenter randomized clinical trial is to compare the tunneling technique of PICC insertion with the non-tunneled insertion technique in the incidence of the...
Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on improvement...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Clabsi - Central Line Associated Bloodstream Infection, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Clabsi - Central Line Associated Bloodstream Infection, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Clabsi - Central Line Associated Bloodstream Infection, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.